TCL Archive Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific August 12, 2011
TCL Archive Bristol-Myers Squibb Co. has agreed to pay $450 million to settle class action suits from shareholders and separate civil claims by the Securities and Exchange Commission. The settlements stem from Bristol’s practice of building up wholesalers’ inventories and diverting operating income to enhance dividends. August 6, 2004
TCL Archive More Debate Due On Organ Site Program; First Round Reviewed By DRG “Slaughtered” January 28, 1983
